Contact Information for physicians/patients
Clinic for Internal Medicine IV (Gastroenterology and Infectious diseases)
Contact:
Uta.merle(at)med.uni-heidelberg.de
Clinic for Children and Adolescent Medicine:
Contact:
Alexander.fichtner(at)med.uni-heidelberg.de (gastroenterology)
christian.staufner(at)med.uni-heidelberg.de (metabolic diseases)
Particular rare liver disease expertise of the centre
- Wilson Disease
- Hereditary Hemochromatosis
- Primary Sclerosing Cholangitis (PSC)
- Primary Biliary Cholangitis (PBC)
- Autoimmune Hepatitis (AIH)
- Genetic Cholestatic Disease
- IgG4-related Disease
- Alpha-1-Antitrypsin Deficiency (A1ATD)
- Acute Liver Failure, Pediatric Acute Liver Failure
- Biliary Atresia
- Progressive familial intrahepatic cholestasis (PFIC)
- Choledochal Cysts
- Hereditary cystic diseases with hepatic manifestations: like ARPKD, Nephronophthisis
- Cystic Liver Disease
- Vascular Liver Disease
- Intrahepatic Cholangiocarcinoma (iCCA) and other rare liver tumours
- Rare metabolic liver diseases
ERN Representatives
-
Dr. Alexander Fichtner
Pediatric gastroenterologist, Pediatric nephrologist
-
Prof. Dr. Uta Merle
Adult gastroenterologist
ERN Team and Contact
Clinic for Internal Medicine IV (Gastroenterology and Infectious diseases)
Contact:
Uta.merle(at)med.uni-heidelberg.de
Clinic for Children and Adolescent Medicine:
Contact:
Alexander.fichtner(at)med.uni-heidelberg.de (gastroenterology)
christian.staufner(at)med.uni-heidelberg.de (metabolic diseases)
Centre information
The ERN Rare-Liver core unit at the University Hospital Heidelberg is on the highest State-of-the-Art level regarding diagnostic and therapeutic expertise and technology – including an intermediate and intensive care unit for treatment of acute liver failure.
The center offers a high level of team cooperation and interaction as well as a multidisciplinary approach to treat difficult and unique cases, offering the highest standards of medical care for rare liver diseases such as Wilson’s disease, hereditary hemochromatosis, primary and secondary sclerosing cholangitis (PSC, SSC), primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), neonatal and adult cholestasis syndromes including biliary malformations and genetic cholestatic diseases such as Allagille syndrome, benign recurrent intrahepatic cholestasis (BRIC), progressive familial intrahepatic cholestasis (PFIC), A1AT deficiency, Polycystic Liver Disease, Rare Liver Tumours of children and adults, Acute Liver Failure (ALF), with particular interest in metabolic diseases affecting the liver. We also focus on participation in national and international treatment guidelines. Moreover, we treat pregnancy related hepatobiliary disorders such as intrahepatic cholestasis of pregnancy (ICP), HELLP syndrome, and acute fatty liver of pregnancy (AFLD) according to state-of-the-art procedures.